162 Followers on Owler

Tizona

Read more
Christine O’Brien's photo - CEO of Tizona

CEO

Christine O’Brien

CEO Approval Rating

90/100

Founded:

2014

Status:

PrivateIndependent Company

Est. Annual Revenue
$3.8M
Agree?
Est. Employees
42
Agree?

TIZONA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Tizona's company profile
Christine O’Brien's photo - CEO of Tizona

Christine O’Brien

CEO

90/100
42
$370M
$3.8M
View Profile
1
Tizona's Competitor - NexImmune logo
Scott P. Carmer's photo - CEO of NexImmune

Scott P. Carmer

CEO

85/100
44
$162.8M
View Profile
2
Tizona's Competitor - Juno Therapeutics logo
CEO Avatar

CEO

- -
1,000
$1.5B
$106M
View Profile
3
Tizona's Competitor - Perthera logo
Gary L. Gregory's photo - President & CEO of Perthera

Gary L. Gregory

President & CEO

81/100
30
$13.4M
$4M
View Profile
4
Tizona's Competitor - bluebird bio logo
Nick Leschly's photo - President & CEO of bluebird bio

Nick Leschly

President & CEO

74/100
764
$526.4M
$50.2M
View Profile
5
Tizona's Competitor - Kite Pharma logo
Christi L. Shaw's photo - CEO of Kite Pharma

Christi L. Shaw

CEO

81/100
2,000
$634.9M
$45M
View Profile
6
Tizona's Competitor - Aura Biosciences logo
Elisabet De Los Pinos's photo - Founder & CEO of Aura Biosciences

Elisabet De Los Pinos

Founder & CEO

85/100
35
$197.7M
$5.6M
View Profile
7
Tizona's Competitor - Sangamo logo
Sandy Macrae's photo - President & CEO of Sangamo

Sandy Macrae

President & CEO

77/100
302
$71.5M
$137.7M
View Profile
8
Tizona's Competitor - Ember Therapeutics logo
CEO Avatar

CEO

- -
3
$1M
$6.4M
View Profile
9
Tizona's Competitor - Recombinetics logo
Mark Platt's photo - CEO of Recombinetics

Mark Platt

CEO

82/100
45
$73.7M
$7.2M
View Profile
10
Tizona's Competitor - Apexigen logo
Xiaodong Yang's photo - President & CEO of Apexigen

Xiaodong Yang

President & CEO

90/100
30
$158M
$7.1M
View Profile
11
Tizona's Competitor - Cedilla logo
Alexandra Glucksmann's photo - President & CEO of Cedilla

Alexandra Glucksmann

President & CEO

90/100
50
$113.8M
$2.5M
View Profile
12
Tizona's Competitor - CR Pharmaceutical logo
CEO Avatar

Han Yuewei

CEO

82/100
66,000
$105.7M
$26.3B
View Profile

Missing a competitor? Contribute!

NexImmune is Tizona's #1 competitor. NexImmune was founded in Gaithersburg, Maryland} in 2011. Like Tizona, NexImmune also competes in the Biotechnology industry. Compared to Tizona, NexImmune generates $ less revenue.

Juno Therapeutics is one of Tizona's top competitors. Juno Therapeutics was founded in 2013 in Seattle, Washington. Like Tizona, Juno Therapeutics also operates in the Biotechnology industry. Juno Therapeutics generates $102.2M more revenue than Tizona.

Perthera is a top competitor of Tizona. Perthera was founded in 2011, and is headquartered in Holliston, Massachusetts. Like Tizona, Perthera also competes in the Biotechnology field. Perthera generates $200K more revenue vs. Tizona.

Tizona Acquisitions

No recent acquisitions found related to Tizona

Tizona Funding History

Since Tizona was founded in 2014, it has participated in 3 rounds of funding. In total Tizona has raised $370.0M. Tizona's last funding round was on Jul 2020 for a total of $300.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Corporate Round
Jul 2020
$300M
Series B
Mar 2016
$43M
Series A
Sep 2015
$27M

Since Tizona was founded in 2014, it has participated in 3 rounds of funding. In total Tizona has raised $370.0M. Tizona's last funding round was on Jul 2020 for a total of $300.0M

Tizona Investments

No recent investments found related to Tizona

Tizona News

July 22, 2020BioPharma-Reporter

Gilead continues equity stake strategy with $300m deal

Gilead buys a stake in Tizona for its cancer immunotherapies, whilst holding the option to buy outrig... See more »
July 21, 2020Venture Capital Journal

Gilead Sciences to invest $300m in VC-backed Tizona Therapeutics

Gilead Sciences Inc has agreed to invest $300 million in Tizona Therapeutics, a clinical-stage immuno... See more »
June 24, 2020MarketScreener

Tizona Initiates Clinical Development of TTX-080 in Advanced Cancers

(marketscreener.com) -- IND Cleared by US FDA with Study Enrollment to Begin in Q3 2020 -- -- First A... See more »
February 19, 2020Benzinga

Tizona to Present at The Cowen and Company 40th Annual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Tizona Therapeutics, Inc., a clinical ... See more »
November 7, 2019BioPortfolio

Tizona Announces Publication in Cancer Discovery Highlighting the Important Role of CD39 and Extracellular ATP in Inflammasomedriven AntiTumor Immunity

AntiCD39 facilitates Tcell infiltration into noninflamed tumors; rescues antiPD1 resistanceTizonas in... See more »
May 15, 2019Talent4Boards

Tizona Therapeutics welcomes Dan Spiegelman to its Board of Directors

Talent4Boards - Great Talent builds Great Boards- USA, CA - Tizona Therapeutics, Inc., a privately he... See more »
January 4, 2019BioPharma Dive

AbbVie puts up $105M for Tizona's preclinical I/O drug

Tizona's lead therapy inhibits an enzyme called CD39, a lesser-known target thought to play a role in... See more »

Tizona Press Releases

Social Media

Tizona Headquarters

4000 Shoreline Court Suite 200

South San Francisco, California94080

1-650-383-0800

Driving Directions »

Trending Companies

Tizona Summary

ABOUT

Overview

Tizona is a biotechnology company that researches, develops and commercializes immunotherapies for the treatment of cancer. Tizona was founded in 2014. Tizona's headquarters is located in South San Francisco, California, USA 94080. It has raised 370.0...

CEO

Tizona's CEO, Christine O’Brien, currently has an approval rating of 90%. Tizona's primary competitors are NexImmune, Juno Therapeutics & Perthera.

Frequently Asked Questions about Tizona

  1. When was Tizona founded?

    Tizona was founded in 2014
  2. Who is Tizona's CEO?

    Tizona's CEO is Christine O’Brien
  3. How much revenue does Tizona generate?

    Tizona generates $3.8M in revenue
  4. How much funding does Tizona have?

    Tizona has historically raised $370M in funding
  1. Where is Tizona's headquarters?

    Tizona's headquarters is in South San Francisco California, USA
  2. How many employees does Tizona have?

    Tizona has 42 employees
  3. What sector does Tizona operate in?

    Tizona is in Biotechnology, Pharmaceuticals
  4. Who are Tizona's competitors?

    Tizona's top competitors are NexImmune, Juno Therapeutics, Perthera